Cellular interactions of the phosphorilated form of Akt in prostate cancer

被引：0
|
作者：
Hammerich., K. [1 ]
Manzoni, A. [1 ]
Wheeler, T. M. [1 ]
Ayala., G. E. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
679
引用
收藏
页码：150A / 150A
页数：1
相关论文
共 50 条
  • [21] The Cellular and Molecular Immunotherapy in Prostate Cancer
    Mukherjee, Anirban Goutam
    Wanjari, Uddesh Ramesh
    Prabakaran, D. S.
    Ganesan, Raja
    Renu, Kaviyarasi
    Dey, Abhijit
    Vellingiri, Balachandar
    Kandasamy, Sabariswaran
    Ramesh, Thiyagarajan
    Gopalakrishnan, Abilash Valsala
    VACCINES, 2022, 10 (08)
  • [22] Molecular and cellular biology of prostate cancer
    Lalani, EN
    Laniado, ME
    Abel, PD
    CANCER AND METASTASIS REVIEWS, 1997, 16 (1-2) : 29 - 66
  • [23] The cellular and molecular basis of prostate cancer
    Foster, CS
    Cornford, P
    Forsyth, L
    Djamgoz, MBA
    Ke, Y
    BJU INTERNATIONAL, 1999, 83 (02) : 171 - 194
  • [24] Targeting AKT signaling sensitizes cancer to cellular immunotherapy
    Haehnel, Patricia S.
    Thaler, Sonja
    Antunes, Edite
    Huber, Christoph
    Theobald, Matthias
    Schuler, Martin
    CANCER RESEARCH, 2008, 68 (10) : 3899 - 3906
  • [25] Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
    Roediger, Julia
    Hessenkemper, Wiebke
    Bartsch, Sophie
    Manvelyan, Marina
    Huettner, Soeren S.
    Liehr, Thomas
    Esmaeili, Mohsen
    Foller, Susan
    Petersen, Iver
    Grimm, Marc-Oliver
    Baniahmad, Aria
    MOLECULAR CANCER, 2014, 13
  • [26] Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
    Julia Roediger
    Wiebke Hessenkemper
    Sophie Bartsch
    Marina Manvelyan
    Soeren S Huettner
    Thomas Liehr
    Mohsen Esmaeili
    Susan Foller
    Iver Petersen
    Marc-Oliver Grimm
    Aria Baniahmad
    Molecular Cancer, 13
  • [27] Androgen receptor levels are upregulated by Akt in prostate cancer
    Ha, Susan
    Ruoff, Rachel
    Kahoud, Nicole
    Franke, Thomas F.
    Logan, Susan K.
    ENDOCRINE-RELATED CANCER, 2011, 18 (02) : 245 - 255
  • [28] Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
    Gasmi, Anis
    Roubaud, Guilhem
    Dariane, Charles
    Barret, Eric
    Beauval, Jean-Baptiste
    Brureau, Laurent
    Crehange, Gilles
    Fiard, Gaelle
    Fromont, Gaelle
    Gauthe, Mathieu
    Ruffion, Alain
    Renard-Penna, Raphaele
    Sargos, Paul
    Roupret, Morgan
    Ploussard, Guillaume
    Mathieu, Romain
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [29] Akt isoforms differentially provide for chemoresistance in prostate cancer
    Ma, Bo
    Shao, Hanshuang
    Jiang, Xia
    Wang, Zhou
    Wu, Chuanyue
    Whaley, Diana
    Wells, Alan
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 635 - 650
  • [30] Akt Isoform-specific Signaling in Prostate Cancer
    Chin, R.
    Toker, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S162 - S162
12345